GridAI Technologies Corp. filings document the formal reporting record for a Nasdaq Capital Market issuer that shifted from Entero Therapeutics into a diversified technology and life sciences company after the Grid AI acquisition. The filings identify GRDX common stock, material-event reports, operating and financial results, capital-structure matters, governance disclosures, shareholder voting matters, risk factors, and material agreements.
Recent 8-K disclosures also record Nasdaq periodic-reporting compliance matters tied to a delayed Form 10-K and the subsequent closure of that issue, as well as direct financial-obligation events under a revolving loan agreement. The filing record connects the company's energy-orchestration operations, legacy gastrointestinal therapeutics activities, financing arrangements, and public-company reporting obligations.
GridAI Technologies Corp. (GRDX) said Manpreet Uppal notified the company that he was resigning from its Board of Directors and all Board committees on which he served, effective October 19, 2026. The company stated that his resignation was not the result of any disagreement about its operations, policies or practices, and thanked him for his service.
GridAI Technologies Corp. (GRDX) covers the resale of up to 9,908,766 shares of Common Stock by selling stockholders; the company is not selling shares under the prospectus. The registered shares comprise 270,192 issued shares, 4,684,191 shares issuable upon exercise of Pre-funded Warrants and 4,954,383 shares issuable upon exercise of Common Warrants. GridAI receives no proceeds from resales, but may receive net proceeds from cash warrant exercises for general working capital.
As of June 30, 2026, GridAI had $1.4 million in cash, an accumulated deficit of $224.9 million and negative working capital of $11.8 million. Assuming full consideration is paid for the May and July 2026 private placements, GridAI anticipates at least 18 months of liquidity; it estimates six months if the registration statement is not declared effective. It warns that if effectiveness does not occur on or before January 2027, it may need to curtail or cease operations before receiving the remaining approximately $12.3 million. Auditors expressed substantial doubt about its ability to continue as a going concern, and management identified a material weakness in internal control over financial reporting. Consulting revenue is expected in approximately four months and SaaS revenue in six to nine months.
GridAI Technologies Corp. (GRDX) reports that its Chief Executive Officer and director, Jason David Sawyer, acquired 250,000 shares of Common Stock when 250,000 restricted stock units vested on September 30, 2026. The units were part of a 1,000,000-unit grant made December 19, 2025. Sawyer held 790,000 shares directly after the transaction.
GridAI Technologies Corp. (GRDX) made a third loan of $536,000 to Pronghorn Resources, LLC, bringing the aggregate principal amount under its Second Amended and Restated Secured Convertible Note to $3,500,000. The total reflects the initial $2,000,000 loan, the additional $964,000 loan reflected in the September 4, 2026 amended note, and the $536,000 third loan reflected in the October 1, 2026 note.
In connection with the Second Amended Note, the parties also entered into a Second Amendment to Security Agreement.
GridAI Technologies Corp. (GRDX) is registering up to 9,908,766 common shares for resale by selling stockholders. Resales may begin only after effectiveness. The amount comprises 270,192 issued shares, 4,684,191 shares issuable under pre-funded warrants and 4,954,383 under common warrants. GridAI receives no resale proceeds but may receive net proceeds from cash exercises for general working capital.
As of June 30, 2026, GridAI had approximately $1.4 million in cash, an accumulated deficit of approximately $224.9 million and negative working capital of approximately $11.8 million. It anticipates sufficient liquidity for planned operations for at least 18 months based on cash and private-placement proceeds, including $12.3 million purchasers agreed to pay before effectiveness; if the registration statement is not effective on or before January 2027, it may need to curtail or cease operations. Annual burn is estimated at $7.8 million.
Auditors expressed substantial doubt about GridAI’s ability to continue as a going concern. It reported a material weakness in internal control over financial reporting and is working to remediate it. Series H shares are not currently convertible; conversion could dilute pre-acquisition holders by approximately 84.5% if milestones are amended or removed and stockholder approval is obtained.
GridAI Technologies Corp. (GRDX) filed an amended quarterly report for the period ended June 30, 2026 to revise and expand its goodwill and critical accounting policy disclosures after SEC staff comments. The amendment clarifies the qualitative description of goodwill from the Grid AI Corp. acquisition, the valuation method for the AI reporting unit, and key assumptions used in impairment testing, but it does not change any previously reported financial statement amounts, including the goodwill impairment charge.
For the six months ended June 30, 2026, GridAI reported revenue of $124,084 and a net loss of $16.5 million, driven largely by a $10.1 million goodwill impairment on the AI reporting unit and high general and administrative expenses. Cash and cash equivalents were about $1.4 million, with a working capital deficit of roughly $11.8 million and an accumulated deficit of about $224.9 million, and management disclosed substantial doubt about the company’s ability to continue as a going concern.
Total assets were $37.0 million, including $14.0 million of goodwill and $20.7 million of finite-lived intangibles related mainly to the Grid AI acquisition, while total liabilities were $18.3 million and stockholders’ equity was $14.9 million. During the first half of 2026 the company raised funding through equity offerings and warrant exercises, increased common shares outstanding to 6,913,198, and continued operating two segments: its legacy gastrointestinal therapeutics business and its newer AI-driven energy optimization platform.
GridAI Technologies Corp. (GRDX) disclosed that on September 4, 2026 it entered into an Amended and Restated Secured Convertible Promissory Note with Pronghorn Resources, LLC, updating a prior $2,000,000 note to reflect a second, additional loan of $964,000.
The Parties also executed a First Amendment to the Security Agreement, revising the definition of “Note” so that the security package now applies to the Amended and Restated Secured Convertible Promissory Note. Both amended agreements are filed as exhibits and incorporated by reference.
GridAI Technologies Corp. (GRDX) filed an amended S-1 to register for resale up to 9,908,766 shares of common stock held by selling stockholders, including shares issuable on exercise of Pre-funded Warrants and Common Warrants from May and July 2026 private placements. GridAI itself is not selling shares and will only receive cash if warrants are exercised for cash.
The company focuses on AI-driven energy orchestration for data centers via Grid AI Corp. and legacy GI drug candidate Adrulipase. As of June 30, 2026, GridAI had $1.4 million in cash, an accumulated deficit of $224.9 million, negative working capital of $11.8 million, a $10.1 million goodwill impairment, and a forecast annual cash burn of $7.8 million. Auditors have expressed substantial doubt about its ability to continue as a going concern.
GridAI has raised or arranged gross proceeds of about $12.5 million across three 2026 private placements, with $4 million already received and $12.3 million contractually to be paid before this registration is effective. If the registration is not declared effective by January 2027, or if additional funding is not obtained, the company states it may need to curtail or cease operations, liquidate, or seek bankruptcy protection. Full conversion of its Series H preferred stock, if milestones and stockholder approval are achieved, would dilute pre-acquisition stockholders’ ownership by about 84.5%.
GridAI Technologies Corp. (GRDX) reports very early-stage revenue and large losses for the six months ended June 30, 2026. Revenue was $124,084 with a gross loss of $650,254, while total operating expenses reached $16,071,004, including a $10,070,124 goodwill impairment related to the 2025 Grid AI acquisition.
Loss from continuing operations was $16,478,995, and net loss applicable to common shareholders was $16,307,455, or $(2.81) per share. Total assets declined to $37,035,600 from $48,551,843 at year-end, with $14,048,553 of goodwill and $20,687,863 of finite-lived intangibles (developed technology, customer relationships and trade name).
Liquidity is strained: cash and cash equivalents were approximately $1.4 million, with a working capital deficit of approximately $11.8 million and accumulated deficit of approximately $224.9 million. Net cash used in operations was $3,291,571, partially offset by $4,144,303 provided by financing activities, including equity and warrant-related issuances. Management discloses that these conditions raise substantial doubt about the company’s ability to continue as a going concern and is evaluating strategic alternatives, including potential mergers, sales, wind-down or bankruptcy.